When severe depression, PTSD, or treatment-resistant conditions demand immediate, comprehensive intervention, HOPE Accelerated Care delivers the full power of neuroplastic medicine on an intensive timeline. For patients who’ve waited too long for relief, who’ve tried treatment after treatment without lasting results, who need something more than standard care can provide—this is the answer. Available at our West Palm Beach location, our accelerated programs combine TMS, SPRAVATO®, and IV Ketamine Therapy in concentrated treatment protocols designed for patients who need robust, immediate access to the most advanced interventions available.
This is neuroplastic therapy at its most intensive. Where traditional treatment unfolds gradually, HOPE Accelerated Care compresses the timeline without compromising effectiveness, bringing together our three most powerful modalities in a coordinated approach that addresses severe mental health conditions with the urgency they demand. This is care designed for the moments when time matters, when severity demands more, when you need everything science can offer working together toward your recovery.
HOPE Accelerated Care represents our commitment to ensuring that when patients need immediate, comprehensive treatment, nothing stands between them and the neuroplastic therapies that can transform their lives. Accelerated care programs are expanding to additional HOPE Therapeutics locations.
HOPE Accelerated Care is our intensive treatment program combining Transcranial Magnetic Stimulation (TMS), SPRAVATO® (intranasal esketamine), and IV Ketamine Therapy on compressed timelines. These three neuroplastic modalities work through different mechanisms to stimulate the brain’s remarkable capacity to reorganize itself, form new neural connections, and break free from entrenched patterns of depression, anxiety, and trauma.
HOPE Accelerated Care brings our most powerful therapies together in an intensive format, creating optimal conditions for rapid neuroplastic change. Each modality enhances the others, working synergistically to address treatment-resistant conditions that haven’t responded to conventional approaches. This is comprehensive intervention delivered with the urgency that severe mental health conditions demand.
Our accelerated programs are designed for patients who need immediate, comprehensive intervention. This is not entry-level care. This is for people facing severe depression, persistent suicidal ideation, debilitating PTSD, or treatment-resistant conditions that demand the most robust therapeutic response we can provide. This is for patients who’ve tried other approaches and need something more powerful. This is for people who can’t afford to wait any longer for relief.
The program is currently offered at HOPE Accelerated Care in West Palm Beach, Florida, with plans to expand accelerated treatment options across our growing network of clinics.
HOPE Accelerated Care serves patients whose mental health conditions require intensive, multi-modality intervention delivered on an accelerated timeline. You might be a candidate if you’re experiencing severe, treatment-resistant depression that hasn’t responded to multiple medications or traditional therapy. If suicidal ideation persists despite treatment, if PTSD symptoms continue to destabilize your life, or if anxiety or OCD have proven resistant to conventional approaches, accelerated care may provide the comprehensive intervention you need.
This program is for patients who need more than standard outpatient treatment can provide. Perhaps you’ve spent months or years cycling through different medications, each promising relief that never fully arrives. Maybe previous treatments offered only partial improvement, leaving you better but not well. Perhaps symptoms return quickly after brief periods of stability, and you recognize that incremental approaches aren’t enough. Your condition may be severe enough that waiting weeks for new treatments to take effect feels impossible when you’re struggling to function each day.
HOPE Accelerated Care is for patients who recognize that their condition demands the most advanced neuroplastic therapies available, delivered with clinical intensity and sophisticated medical monitoring. These are FDA-approved and clinically-validated treatments provided in a concentrated format designed to accelerate your path to recovery. This is care for people who need something more—more comprehensive, more immediate, more powerful—than what they’ve received before.
Our team conducts comprehensive evaluations to determine if accelerated treatment is appropriate for your specific situation. Not every patient requires this level of intensity, but for those who do, HOPE Accelerated Care provides immediate access to our most powerful therapeutic interventions.
TMS uses focused magnetic pulses to stimulate specific regions of the brain involved in mood regulation, particularly the dorsolateral prefrontal cortex. This completely non-invasive treatment normalizes dysfunctional connectivity within and between large-scale brain networks, enhancing emotion regulation and cognitive control. The technology received FDA approval for major depressive disorder in 2008 and has since earned clearance for obsessive-compulsive disorder, with extensive research demonstrating effectiveness for anxiety and other conditions.
In accelerated protocols, TMS sessions are delivered in concentrated formats that compress traditional four-to-six-week treatment courses into shorter timeframes. Recent research has validated accelerated TMS approaches, with studies showing that intensive protocols can produce rapid antidepressant effects while maintaining the safety profile established over nearly two decades of clinical use. Accelerated TMS creates an intensive neuroplastic environment, stimulating new neural connections at an accelerated pace.
Unlike medications, TMS produces no systemic side effects such as weight gain, sexual dysfunction, or cognitive impairment. Patients can drive themselves to and from appointments and immediately resume daily activities. Each session is brief, typically lasting less than 30 minutes, making intensive treatment schedules feasible even for patients with demanding responsibilities.
SPRAVATO® is the first and only FDA-approved nasal spray specifically for adults with treatment-resistant depression. In January 2025, the FDA expanded approval to allow SPRAVATO® to be used as monotherapy, making it the first and only standalone treatment for adults who haven’t responded to at least two oral antidepressants. SPRAVATO® is also approved for use in patients with acute suicidal ideation and behavior, though it is not proven to prevent suicide.
This medication works differently than traditional antidepressants. Rather than targeting serotonin or norepinephrine, SPRAVATO® modulates the glutamate system through NMDA receptor antagonism, promoting neuroplasticity and helping the brain form new synapses. Clinical trials demonstrate that SPRAVATO® can produce significant improvements in depressive symptoms within 24 hours of administration, with effects sustained through weeks of treatment.
During SPRAVATO® sessions, qualified clinicians supervise as patients self-administer the nasal spray. Following administration, patients rest comfortably while being monitored for approximately two hours. Common side effects include transient nausea, dizziness, and dissociation, which typically resolve before the observation period ends. The rapid onset of therapeutic effects makes SPRAVATO® particularly valuable in intensive treatment protocols where speed of response matters.
IV Ketamine has been described as potentially “the most important discovery in psychiatry in the past fifty years.” Originally FDA-approved as an anesthetic in 1970, ketamine’s powerful antidepressant effects at subanesthetic doses were discovered by Yale researchers in the early 2000s. Over two decades of research has demonstrated that IV Ketamine is highly effective in treating depression, suicidal ideation, PTSD, anxiety, OCD, and substance use disorders, even in patients who haven’t responded to conventional medications.
Ketamine works through glutamatergic neurotransmission, antagonizing NMDA receptors and triggering a cascade of neuroplastic changes. These changes include increased synaptic plasticity, enhanced neural connectivity, and activation of neurotrophic factors that support brain health and recovery. The antidepressant effects often begin within hours of infusion, representing a dramatic departure from the weeks-long wait associated with traditional psychiatric medications.
In intensive treatment protocols, IV Ketamine infusions can be administered on compressed schedules that accelerate the accumulation of therapeutic benefits. Research demonstrates that repeated ketamine infusions produce more pronounced and durable effects than single administrations, with response rates of 60-70% in treatment-resistant populations. The infusions are well-tolerated, with side effects typically limited to transient increases in blood pressure and mild dissociative experiences during the 40-minute infusion period.
The power of HOPE Accelerated Care lies not just in the individual effectiveness of each modality, but in how they work together to create optimal conditions for rapid neuroplastic change. Each therapy approaches brain function through different mechanisms, yet all share a common goal: stimulating the brain’s innate capacity to reorganize, adapt, and heal.
TMS uses magnetic fields to directly stimulate neural activity in mood-regulating brain regions, normalizing connectivity and enhancing cognitive control. SPRAVATO® and IV Ketamine both modulate glutamate signaling through NMDA receptor antagonism, but through different routes of administration and with distinct pharmacological profiles. Together, these interventions create a synergistic neuroplastic environment that may accelerate recovery beyond what any single treatment could achieve alone.
Recent consensus reviews emphasize that TMS has evolved significantly beyond its initial protocols, with accelerated approaches showing promise for patients who need rapid intervention. Studies published in 2025 demonstrate that intensive TMS protocols can compress weeks of treatment into days while maintaining efficacy and safety. When combined with rapid-acting antidepressants like ketamine and esketamine, the neuroplastic window opens wider and potentially longer, allowing for deeper therapeutic change.
The compressed timeline of accelerated treatment also offers practical benefits. Rather than spreading treatment across months of weekly or twice-weekly appointments, intensive protocols deliver therapeutic dosing in concentrated bursts that may better align with the natural mechanisms of neuroplastic change. Research suggests that intensive intervention during acute phases of illness may produce better outcomes than gradual escalation, particularly for severe or treatment-resistant conditions.
This is precision neuroplasticity: multiple mechanisms, working simultaneously, creating the conditions for rapid transformation when patients need it most.
Your journey with HOPE Accelerated Care begins with a comprehensive evaluation by our clinical team. This assessment examines your diagnosis, treatment history, current symptoms, and overall health status to determine if accelerated treatment is appropriate and safe for your specific situation. We review previous medications and therapies you’ve tried, identify any contraindications, and discuss your goals and expectations for treatment.
If you’re approved for the program, we develop a customized intensive treatment plan that may combine TMS, SPRAVATO®, and IV Ketamine in a schedule designed to maximize therapeutic benefit. Treatment is delivered in a concentrated timeframe with close medical monitoring throughout. Our team tracks your response carefully, adjusting protocols as needed to optimize outcomes while maintaining safety.
The treatment environment at HOPE Accelerated Care is designed for comfort and healing. You’ll receive care in a modern, supportive setting where every detail has been considered to reduce stress and promote recovery. Our clinical staff includes experienced medical professionals who specialize in interventional psychiatry and understand the complexities of treatment-resistant mental health conditions.
Throughout the program, you’ll have regular contact with our medical team. We monitor both therapeutic progress and any side effects, ensuring you’re tolerating treatment well and responding as expected. Most side effects from these treatments are mild and transient, resolving quickly after each session. Serious adverse events are rare when treatments are administered under proper medical supervision.
After completing the intensive phase of treatment, we help you transition to appropriate maintenance care. For some patients, this means scheduled maintenance sessions to sustain the benefits achieved during accelerated treatment. For others, it involves transitioning back to outpatient psychiatric care with ongoing medication management or therapy. Our goal is to ensure that the improvements you experience during HOPE Accelerated Care are maintained over the long term.
When multiple antidepressants have failed to provide relief, when depression is severe and destabilizing, or when rapid intervention is needed, accelerated treatment delivers the comprehensive therapeutic response these conditions demand.
Persistent thoughts of self-harm require immediate, intensive treatment. Our combination of rapid-acting therapies addresses suicidal ideation with the urgency it demands, though patients in acute suicidal crisis require emergency psychiatric evaluation before beginning treatment.
Trauma that continues to control your life despite therapy, flashbacks and hypervigilance that won’t subside, emotional numbing that prevents connection—PTSD demands intensive intervention, and our neuroplastic therapies have demonstrated effectiveness in reducing trauma symptoms where conventional approaches have fallen short.
Severe anxiety that interferes with daily functioning, panic attacks that persist despite medication, or generalized anxiety that hasn’t responded to traditional treatment may benefit from the combined neuroplastic approach of accelerated care.
When intrusive thoughts and compulsive behaviors resist conventional treatment, when OCD symptoms are severe enough to be disabling, intensive neuroplastic intervention can help break the cycle and restore functioning.
Addiction and substance abuse often co-occur with depression, anxiety, and trauma. IV Ketamine has demonstrated effectiveness in treating substance use disorders, particularly when combined with comprehensive addiction treatment. Our accelerated approach addresses both the addiction and underlying mental health conditions simultaneously.
The scientific foundation for accelerated mental health treatment has strengthened considerably in recent years. A 2025 consensus review endorsed by the National Network of Depression Centers, the Clinical TMS Society, and the International Federation of Clinical Neurophysiology examined over 2,300 studies on TMS and depression. The review concluded that accelerated protocols show promising early findings, with some approaches compressing traditional treatment timelines while maintaining efficacy.
Research on ketamine and esketamine supports the rapid-acting antidepressant effects that make these medications particularly valuable in intensive protocols. A 2025 randomized clinical trial published in JAMA Psychiatry demonstrated that esketamine monotherapy produced statistically significant and clinically meaningful improvements in treatment-resistant depression, with initial effects observed within 24 hours and maintained through day 28 of treatment. Both the 56mg and 84mg doses significantly outperformed placebo across all measured outcomes.
The neurobiological mechanisms underlying these treatments converge on neuroplasticity—the brain’s ability to reorganize neural networks in response to experience and intervention. Comprehensive reviews published in 2022 detail how ketamine promotes synaptogenesis, enhances connectivity in mood-regulating circuits, and activates neurotrophic factors that support brain health. These molecular changes create a window of enhanced plasticity during which therapeutic interventions may have amplified effects.
Intensive treatment protocols leverage this neuroplastic window by delivering multiple therapeutic inputs during the period when the brain is most receptive to change. Rather than spacing interventions across months, accelerated approaches concentrate therapeutic dosing during acute phases of illness when intervention may be most effective. The science suggests this is not just about convenience or speed—it’s about creating optimal conditions for neurobiological transformation.
HOPE Accelerated Care is backed by the full clinical and scientific expertise of HOPE Therapeutics and our parent company, NRx Pharmaceuticals. Our medical director, Dr. Rebecca S. Cohen, MD, FAPA, FCTMSS, is a nationally recognized expert in interventional psychiatry and Transcranial Magnetic Stimulation. Our VP of Clinical Services, LTC Charles Paul, RN (US Army, Ret.), brings two decades of experience administering emergency medicine in combat conditions—experience that translates directly to managing intensive psychiatric interventions with precision and composure.
Our Scientific Advisory Board includes Gerard Sanacora, PhD, MD, whose initial discovery on the role of NMDA antagonists in psychiatric disorders laid the groundwork for ketamine and esketamine therapy. With over 760 publications, Dr. Sanacora is among the world’s leading experts on rapid-acting antidepressants. This depth of scientific expertise informs every aspect of our treatment approach.
HOPE Therapeutics operates from a mission: to render suicidal depression and PTSD curable diseases with rapid results through state-of-the-art neuroplastic therapy, and to offer hope to patients and families without stigma. We envision a future where mental healthcare becomes a story of hope—where people can end any chapter by saying, “Everything’s okay, we went to a HOPE Clinic.” HOPE Accelerated Care advances this mission by ensuring that when patients need comprehensive, immediate intervention, they can access it.
Our facilities are designed for intensive treatment, with modern equipment, experienced clinical staff, and comprehensive monitoring capabilities. We don’t just administer treatments—we create the conditions for healing, providing the medical sophistication and clinical support that intensive psychiatric interventions require.
HOPE Accelerated Care is currently available at our West Palm Beach, Florida location, with accelerated treatment programs expanding to additional HOPE Therapeutics clinics in the future. Beginning treatment starts with a comprehensive consultation to evaluate your condition, review your treatment history, and determine if intensive accelerated care is appropriate for your situation.
During this evaluation, our clinical team will discuss the potential benefits and risks of accelerated treatment, explain what to expect during the program, and answer your questions about logistics, timeline, and outcomes. We’ll assess any medical conditions that might affect treatment safety and review any medications you’re currently taking. This thorough evaluation ensures that if you proceed with HOPE Accelerated Care, you do so with a clear understanding and appropriate medical oversight.
If you’re approved for the program, we’ll develop your customized treatment plan and schedule your intensive sessions. Our administrative team will coordinate the practical details while our clinical staff prepares to deliver the comprehensive care you need.
For patients facing severe, treatment-resistant conditions, HOPE Accelerated Care represents a pathway to rapid recovery through the most advanced neuroplastic therapies available. When conventional treatment hasn’t worked, when symptoms are severe and destabilizing, when you need immediate access to comprehensive intervention—this is what we built HOPE Accelerated Care to provide.
HOPE Accelerated Care combines TMS, SPRAVATO®, and IV Ketamine in intensive treatment protocols delivered on compressed timelines. Rather than trying treatments sequentially over months, our accelerated programs bring multiple neuroplastic modalities together to create optimal conditions for rapid improvement. This is intensive, comprehensive intervention designed for patients whose conditions demand more than traditional outpatient care can provide.
Ideal candidates are patients with severe, treatment-resistant depression, persistent suicidal ideation, debilitating PTSD, or other serious mental health conditions that haven’t responded to conventional treatment. You may be a candidate if you need immediate, comprehensive intervention delivered with clinical sophistication. Our evaluation process determines if accelerated care is appropriate for your specific situation.
Treatment timelines are customized based on individual needs, condition severity, and treatment response. The “accelerated” aspect refers to the intensive nature of the protocols—delivering comprehensive neuroplastic intervention in a concentrated format rather than spreading treatment across many months. During your consultation, we’ll discuss the expected timeline for your specific treatment plan.
TMS is FDA-approved for major depressive disorder and obsessive-compulsive disorder, with expanded approval in 2024 to include adolescents aged 15-21. SPRAVATO® is FDA-approved for treatment-resistant depression (as both monotherapy and adjunctive treatment) and for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. IV Ketamine is FDA-approved as an anesthetic; its use for psychiatric conditions is off-label but supported by extensive research and included in treatment guidelines for severe depression.
We treat depression (including treatment-resistant depression), suicidal ideation, PTSD, anxiety disorders, OCD, substance use disorders, and eating disorders. These conditions share common features: severity, resistance to conventional treatment, and the need for intensive intervention. Our evaluation process determines if your specific condition is appropriate for accelerated treatment.
Our evaluation process helps determine the appropriate level of care for your situation. If you’ve tried multiple treatments without adequate relief, if your symptoms are severe and destabilizing, if you’re facing treatment-resistant depression or persistent suicidal ideation, or if you recognize that your condition demands immediate, comprehensive intervention—contact us for a consultation. We’ll assess your needs and recommend the treatment approach most likely to help you achieve recovery.
You’ve been fighting long enough. When depression won’t lift despite trying multiple medications, when suicidal thoughts persist despite treatment, when PTSD continues to destabilize your life despite therapy—you deserve more than conventional care can provide. You deserve the full power of neuroplastic medicine, delivered intensively, with clinical sophistication and urgent attention to your recovery.
HOPE Accelerated Care represents our commitment to ensuring that when patients face their darkest moments, when conventional treatment hasn’t worked, when hope feels distant—comprehensive, immediate intervention is available. Our intensive programs combine TMS, SPRAVATO®, and IV Ketamine on accelerated timelines, creating optimal conditions for rapid neuroplastic change when you need it most. This is care designed for patients who need breakthroughs, not incremental improvements. Care for people who can’t wait weeks or months for new treatments to maybe work. Care that recognizes severe conditions demand sophisticated, immediate responses.
This is what we built HOPE Therapeutics to provide: transformative care for conditions that destabilize lives, delivered with scientific rigor and genuine hope for recovery. When mental healthcare becomes a story of hope, it often begins with the decision to seek comprehensive intervention rather than continuing to struggle with treatments that haven’t worked. It begins with recognizing that you’ve done everything you were supposed to do—and you deserve access to treatments powerful enough to match the severity of what you’re facing.
Recovery is possible. Relief can come faster than you think. Neuroplastic therapies are changing what’s possible in psychiatry—making rapid improvement achievable even in the most treatment-resistant conditions. You don’t have to keep waiting. You don’t have to keep struggling through approaches that haven’t worked. HOPE Accelerated Care exists because some conditions demand more, and some patients deserve immediate access to the most powerful treatments we have.
HOPE Therapeutics / NRx Pharmaceuticals is committed to protecting and respecting your privacy, and we’ll only use your personal information to contact you if you subscribe to our newsletter. You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and our commitment to protecting and respecting your privacy, please review our Privacy Policy. By clicking submit below, you consent to allow HOPE Therapeutics / NRx Pharmaceuticals to store and process the personal information submitted above to provide you with the content requested.
Effective Date: Jan 1st, 2026
1. Program Description: This messaging program sends appointment confirmation and reminder messages to customers who have booked an appointment with Hope Therapeutics through our website at https://hopetherapeutics.com/, or via our scheduling forms, and have explicitly opted in to receive SMS notifications. Opt-in is collected via web forms with a dedicated checkbox for SMS consent. Messages include scheduling confirmations, appointment reminders, rescheduling updates, and customer support communications.
2. Cancellation Instructions: You can cancel the SMS service at any time. Simply text “STOP” to the same number that sent you messages. Upon sending “STOP,” we will confirm your unsubscribe status via SMS. Following this confirmation, you will no longer receive SMS messages from us. To rejoin, sign up as you did initially, and we will resume sending SMS messages to you.
3. Support Information: If you experience issues with the messaging program, reply with the keyword “HELP” for more assistance, or reach out directly to team@hopetherapeutics.com or call 833-446-7386 during business hours.
4. Carrier Liability: Carriers are not liable for delayed or undelivered messages.
5. Message & Data Rates: Message and data rates may apply for messages sent to you from us and to us from you. Message frequency varies based on your service usage and appointment schedule. For questions about your text plan or data plan, contact your wireless provider.
6. Supported Carriers: Our SMS program works with all major U.S. wireless carriers, including AT&T, T-Mobile, Verizon, Sprint, and most regional carriers.
7. Age Restriction: You must be 18 years or older to participate in our SMS program.
8. Privacy Policy: For privacy-related inquiries, please refer to our Privacy Policy at https://hopetherapeutics.com/privacy-policy
We comply with all applicable laws and regulations, including the Telephone Consumer Protection Act (TCPA) and CTIA guidelines, regarding the use of SMS communications.
This website (the “Site”) is owned and operated by Hope Therapeutics (“COMPANY,” “we” or “us”). By using the Site, you agree to be bound by these Terms of Service and to use the Site in accordance with these Terms of Service, our Privacy Policy, and any additional terms and conditions that may apply to specific sections of the Site or to products and services available through the Site or from Hope Therapeutics.
Accessing the Site, in any manner, whether automated or otherwise, constitutes use of the Site and your agreement to be bound by these Terms of Service.
We reserve the right to change these Terms of Service or to impose new conditions on the use of the Site from time to time, in which case we will post the revised Terms of Service on this website. By continuing to use the Site after we post any such changes, you accept the Terms of Service, as modified.
This Site and all the materials available on the Site are the property of Hope Therapeutics and/or our affiliates or licensors and are protected by copyright, trademark, and other intellectual property laws. The Site is provided solely for your personal non-commercial use.
You may not use the Site or the materials available on the Site in a manner that constitutes an infringement of our rights or that has not been authorized by us.
Unless explicitly authorized, you may not modify, copy, reproduce, republish, upload, post, transmit, translate, sell, create derivative works, exploit, or distribute in any manner or medium any material from the Site. However, you may download and/or print one copy of individual pages for your personal, non-commercial use, provided that you keep intact all copyright and other proprietary notices.
By posting or submitting any material (including comments, blog entries, social media posts, photos, and videos) to us via the Site, internet groups, or other digital venues, you represent that you own the material or have obtained the necessary permissions. You grant us a royalty-free, perpetual, irrevocable, non-exclusive, worldwide license to use, modify, transmit, sell, exploit, create derivative works from, distribute, and publicly perform or display such material.
Throughout the Site, we may provide links and pointers to Internet sites maintained by third parties. Our linking to such third-party sites does not imply an endorsement or sponsorship of such sites or the information, products, or services offered on or through the sites.
The information, products, and services offered on or through the Site are provided “as is” and without warranties of any kind, either express or implied. To the fullest extent permissible pursuant to applicable law, we disclaim all warranties, including implied warranties of merchantability and fitness for a particular purpose.
You agree at all times to indemnify and hold harmless Hope Therapeutics, its affiliates, and their respective officers, directors, agents, and employees from any claims, causes of action, damages, liabilities, costs, and expenses arising out of or related to your breach of any obligation, warranty, or representation under these Terms of Service.
Certain sections of the Site may allow you to purchase products and services from third-party vendors. We are not responsible for the quality, accuracy, timeliness, reliability, or any other aspect of these products and services. If you make a purchase from a third party linked through the Site, the information obtained during your visit, including payment information, may be collected by both the merchant and us.
Your participation in any dealings with third-party vendors is solely between you and the third party. Hope Therapeutics shall not be responsible for any loss or damage incurred as a result of such dealings.
To access certain features of the Site, you may be required to register and create an account. You agree to provide accurate, current, and complete information during the registration process. You are responsible for maintaining the confidentiality of your login credentials and for all activities conducted under your account.
If you suspect unauthorized use of your account, notify us immediately at team@hopetherapeutics.com. We are not liable for any loss or damage arising from your failure to comply with this obligation.
We reserve the right to terminate or suspend your access to the Site, without notice, if we determine that you have violated these Terms of Service or engaged in conduct that we deem inappropriate or unlawful. Upon termination, you must cease all use of the Site and any content obtained from it.
These Terms of Service shall be governed by and construed in accordance with the laws of the state of Florida. Any dispute arising under these Terms shall be resolved exclusively through binding arbitration in that jurisdiction.
We may update these Terms of Service from time to time. The latest version will always be available on our website with the effective date.
For any questions regarding these Terms of Service, please contact us at:
Hope Therapeutics
Phone: 833-446-7386
Email: team@hopetherapeutics.com
Website: https://hopetherapeutics.com/
By using our website and services, you consent to these Terms of Service.
Effective Date: Jan 1st, 2026
IMPORTANT NOTICE REGARDING TEXT MESSAGING
DATA
Hope Therapeutics (“we,” “us,” or “our”) DOES NOT share customer opt-in information, including phone numbers and consent records, with any affiliates or third parties for marketing, promotional, or any other purposes unrelated to providing our direct services. All text messaging originator opt-in data is kept strictly confidential.
We collect the following types of information:
We use collected data for:
By opting into our SMS messaging services, you agree to receive text messages related to our services, including appointment reminders, customer support, and important updates.
No mobile information will be shared with third parties/affiliates for marketing/promotional purposes. Information sharing to subcontractors in support services, such as customer service is permitted. All other use case categories exclude text messaging originator opt-in data and consent; this information will not be shared with any third parties.
We implement strict data protection measures to safeguard your SMS opt-in information and consent records.
We do not sell, rent, or trade personal information. We may share information with:
All the above categories exclude text messaging originator opt-in data and consent; this information will not be shared with any third parties, excluding aggregators and providers of the Text Message services.
We implement and maintain reasonable security measures to protect your personal information:
Despite these measures, no method of transmission over the Internet or electronic storage is 100% secure. We strive to use commercially acceptable means to protect your personal information but cannot guarantee absolute security.
We use cookies and similar technologies to:
You may control cookies through your browser settings. Disabling cookies may limit your ability to use certain features of our website.
You have the right to:
To exercise these rights, please contact us using the information in Section 10.
Our website may contain links to third-party websites. We are not responsible for their privacy practices and encourage you to review their policies. This privacy policy applies only to information collected by Hope Therapeutics.
We may update this policy periodically. The latest version will always be available on our website with the effective date. For significant changes, we will notify you by email or through a notice on our website.
If you have questions about this Privacy Policy or how your information is handled, contact us at:
Hope Therapeutics
Phone: 833-446-7386
Email: team@hopetherapeutics.com
Website: https://hopetherapeutics.com/
By using our website and services, you consent to this Privacy Policy.